Citadel Advisors LLC Has $483,000 Stake in RadNet Inc. (RDNT)

Citadel Advisors LLC increased its position in RadNet Inc. (NASDAQ:RDNT) by 42.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 47,798 shares of the medical research company’s stock after acquiring an additional 14,236 shares during the quarter. Citadel Advisors LLC’s holdings in RadNet were worth $483,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Wells Fargo & Company MN lifted its position in RadNet by 1.9% during the second quarter. Wells Fargo & Company MN now owns 35,843 shares of the medical research company’s stock valued at $278,000 after purchasing an additional 654 shares during the last quarter. Alliancebernstein L.P. lifted its position in RadNet by 101.5% during the second quarter. Alliancebernstein L.P. now owns 27,000 shares of the medical research company’s stock valued at $209,000 after purchasing an additional 13,600 shares during the last quarter. Teachers Advisors LLC lifted its position in RadNet by 10.1% during the second quarter. Teachers Advisors LLC now owns 66,105 shares of the medical research company’s stock valued at $512,000 after purchasing an additional 6,046 shares during the last quarter. TIAA CREF Investment Management LLC lifted its position in RadNet by 19.7% during the second quarter. TIAA CREF Investment Management LLC now owns 124,612 shares of the medical research company’s stock valued at $966,000 after purchasing an additional 20,520 shares during the last quarter. Finally, Northern Trust Corp lifted its position in RadNet by 5.2% during the second quarter. Northern Trust Corp now owns 436,407 shares of the medical research company’s stock valued at $3,382,000 after purchasing an additional 21,746 shares during the last quarter. Institutional investors own 56.53% of the company’s stock.

How to Become a New Pot Stock Millionaire

Several equities research analysts have issued reports on the stock. Jefferies Group set a $14.00 target price on shares of RadNet and gave the company a “buy” rating in a research report on Thursday. BidaskClub upgraded shares of RadNet from a “sell” rating to a “hold” rating in a research report on Saturday, January 6th. Finally, Zacks Investment Research upgraded shares of RadNet from a “hold” rating to a “buy” rating and set a $11.00 target price for the company in a research report on Thursday, January 4th.

Shares of RadNet Inc. (RDNT) opened at $11.80 on Friday. RadNet Inc. has a 1 year low of $5.25 and a 1 year high of $11.90. The stock has a market cap of $492.91, a P/E ratio of 51.30, a price-to-earnings-growth ratio of 2.48 and a beta of 0.69. The company has a debt-to-equity ratio of 7.88, a quick ratio of 1.29 and a current ratio of 1.29.

RadNet (NASDAQ:RDNT) last announced its earnings results on Thursday, March 8th. The medical research company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.01). RadNet had a net margin of 1.21% and a return on equity of 23.73%. The company had revenue of $235.50 million for the quarter, compared to the consensus estimate of $228.46 million. During the same quarter in the previous year, the firm earned $0.08 earnings per share. The company’s revenue for the quarter was up 4.7% compared to the same quarter last year. equities research analysts anticipate that RadNet Inc. will post 0.35 EPS for the current year.

In other news, insider John V. Crues sold 19,684 shares of the business’s stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $10.01, for a total value of $197,036.84. Following the completion of the sale, the insider now directly owns 544,097 shares in the company, valued at approximately $5,446,410.97. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Norman R. Hames sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 20th. The stock was sold at an average price of $9.96, for a total transaction of $49,800.00. Following the completion of the sale, the executive vice president now owns 365,087 shares of the company’s stock, valued at $3,636,266.52. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 42,184 shares of company stock valued at $418,137. Company insiders own 9.36% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at https://sportsperspectives.com/2018/03/10/citadel-advisors-llc-has-483000-stake-in-radnet-inc-rdnt.html.

RadNet Company Profile

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Want to see what other hedge funds are holding RDNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RadNet Inc. (NASDAQ:RDNT).

Institutional Ownership by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply